Pharmacological Activation of Neuronal Voltage-Gated Kv7/KCNQ/M-Channels for Potential Therapy of Epilepsy and Pain
The DOI matches its Crossref record; 106 of the 107 references it cites were found in a registry or an index.
Abstract
Native M-current is a low-threshold, slowly activating potassium current that exerts an inhibitory control over neuronal excitability. The M-channel is primarily co-assembled by heterotetrameric Kv7.2/KCNQ2 and Kv7.3/KCNQ3 subunits that are specifically expressed in the brain and peripheral nociceptive and visceral sensory neurons in the spinal cord. Reduction of M-channel function leads to neuronal hyperexcitability that defines the fundamental mechanism of neurological disorders such as epilepsy and pain, indicating that pharmacological activation of Kv7/KCNQ/M-channels may serve the basis for the therapy. The well-known KCNQ opener retigabine (ezogabine or Potiga) was approved by FDA in 2011 as an anticonvulsant used for an adjunctive treatment of partial epilepsies. Unfortunately, retigabine was discontinued in 2017 due to its side effects of blue-colored appearance of the skin and eyes after prolonged intake. In addition, flupirtine, a structural derivative of retigabine and a centrally acting non-opioid analgesic, was also withdrawn in 2018 for liver toxicity. Fortunately, these side effects are compound-structures related and can be avoided. Thus, further identification and development of novel potent and selective Kv7 channel openers may lead to an effective therapy with improved safety window for anti-epilepsy and anti-nociception.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Kv7 potassium channel enhancer QO-83, a small-molecule KCNQ/Kv7 channel opener, limits infarct volume, edema, and cognitive decline after ischemic injury while curbing microglial activation, pointing to attenuation of excitotoxic cascades that often follow stress or drug withdrawal [252,255,256,257].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [256]
In the citing paper
“Beyond mood, ezogabine reduces cortical and spinal motor neuron excitability in amyotrophic lateral sclerosis and decreases seizure frequency in refractory epilepsy, demonstrating target engagement in human hyperexcitable states and supporting its transdiagnostic potential to quiet unstable circuits [256,262,263].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [256]
In the citing paper
“Pan-selective Kv7 openers such as Lu AA41178, a brain-penetrant Kv7.2–Kv7.5 potassium channel activator, extend these findings, reducing depressive-like behavior while elevating seizure thresholds without major off-target liabilities, suggesting a favorable translatability profile for network stabilization [255,256].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [256]
Citations
Cites
Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone
Brown, D. A., & Adams, P. R. (1980) · Nature · doi:10.1038/283673a0 · Cited by 1,444
KCNQ2 and KCNQ3 Potassium Channel Subunits: Molecular Correlates of the M-Channel
Wang, H. (1998) · Science · doi:10.1126/science.282.5395.1890 · Cited by 1,294
A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns
Singh, N. A., Charlier, C., Stauffer, D., DuPont, B. R., Leach, R. J., Melis, R., Ronen, G. M., Bjerre, I., Quattlebaum, T., Murphy, J. V., et al. (1998) · Nature Genetics · doi:10.1038/ng0198-25 · Cited by 1,199
A Potassium Channel Mutation in Neonatal Human Epilepsy
Biervert, C., Schroeder, B. C., Kubisch, C., Berkovic, S. F., Propping, P., Jentsch, T. J., & Steinlein, O. K. (1998) · Science · doi:10.1126/science.279.5349.403 · Cited by 1,073
A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family
Charlier, C., Singh, N. A., Ryan, S. G., Lewis, T. B., Reus, B. E., Leach, R. J., & Leppert, M. (1998) · Nature Genetics · doi:10.1038/ng0198-53 · Cited by 937
Neyroud, N., Tesson, F., Denjoy, I., Leibovici, M., Donger, C., Barhanin, J., Fauré, S., Gary, F., Coumel, P., Petit, C., et al. (1997) · Nature Genetics · doi:10.1038/ng0297-186 · Cited by 891
Kubisch, C., Schroeder, B. C., Friedrich, T., Lütjohann, B., El-Amraoui, A., Marlin, S., Petit, C., & Jentsch, T. J. (1999) · Cell · doi:10.1016/s0092-8674(00)80556-5 · Cited by 867
Pathways modulating neural KCNQ/M (Kv7) potassium channels
Delmas, P., & Brown, D. A. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1785 · Cited by 686
Zhang, H., Craciun, L. C., Mirshahi, T., Rohács, T., Lopes, C. M. B., Jin, T., & Logothetis, D. E. (2003) · Neuron · doi:10.1016/s0896-6273(03)00125-9 · Cited by 523
Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy
Schroeder, B. C., Kubisch, C., Stein, V., & Jentsch, T. J. (1998) · Nature · doi:10.1038/25367 · Cited by 521
Peters, H. C., Hu, H., Pongs, O., Storm, J. F., & Isbrandt, D. (2005) · Nature Neuroscience · doi:10.1038/nn1375 · Cited by 423
Tatulian, L., Delmas, P., Abogadie, F. C., & Brown, D. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05535.2001 · Cited by 406
KCNQ5, a Novel Potassium Channel Broadly Expressed in Brain, Mediates M-type Currents
Schroeder, B. C., Hechenberger, M., Weinreich, F., Kubisch, C., & Jentsch, T. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003245200 · Cited by 387
KCNQ/M Channels Control Spike Afterdepolarization and Burst Generation in Hippocampal Neurons
Yue, C., & Yaari, Y. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0765-04.2004 · Cited by 369
KCNQ/M Currents in Sensory Neurons: Significance for Pain Therapy
Passmore, G. M., Selyanko, A. A., Mistry, M., Al-Qatari, M., Marsh, S. J., Matthews, E. A., Dickenson, A. H., Brown, T. A., Burbidge, S. A., Main, M., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07227.2003 · Cited by 366
Retigabine, A Novel Anti-Convulsant, Enhances Activation of KCNQ2/Q3 Potassium Channels
Wickenden, A. D., Yu, W., Zou, A., Jegla, T., & Wagoner, P. K. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12425-x · Cited by 320
Singh, N. A. (2003) · Brain · doi:10.1093/brain/awg286 · Cited by 310
Modulation of KCNQ2/3 Potassium Channels by the Novel Anticonvulsant Retigabine
Main, M. J., Cryan, J. E., Dupere, J. R. B., Cox, B., Clare, J. J., & Burbidge, S. A. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12060-3 · Cited by 299
Structural Basis of Human KCNQ1 Modulation and Gating
Sun, J., & MacKinnon, R. (2020) · Cell · doi:10.1016/j.cell.2019.12.003 · Cited by 293
Liu, B., Linley, J. E., Du, X., Zhang, X., Ooi, L., Zhang, H., & Gamper, N. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41084 · Cited by 289
Lerche, C., Scherer, C. R., Seebohm, G., Derst, C., Wei, A. D., Busch, A. E., & Steinmeyer, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002378200 · Cited by 277
Molecular Determinants of KCNQ (Kv7) K+Channel Sensitivity to the Anticonvulsant Retigabine
Schenzer, A., Friedrich, T., Pusch, M., Saftig, P., Jentsch, T. J., Grötzinger, J., & Schwake, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0128-05.2005 · Cited by 267
Wuttke, T. V., Seebohm, G., Bail, S., Maljevic, S., & Lerche, H. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.010793 · Cited by 262
AKAP150 signaling complex promotes suppression of the M-current by muscarinic agonists
Hoshi, N., Zhang, J.-S., Omaki, M., Takeuchi, T., Yokoyama, S., Wanaverbecq, N., Langeberg, L. K., Yoneda, Y., Scott, J. D., Brown, D. A., et al. (2003) · Nature Neuroscience · doi:10.1038/nn1062 · Cited by 244
Rundfeldt, C., & Netzer, R. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00866-1 · Cited by 242
D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures
Rostock, A., Tober, C., Rundfeldt, C., Bartsch, R., Engel, J., Polymeropoulos, E. E., Kutscher, B., Löscher, W., Hönack, D., White, H. S., et al. (1996) · Epilepsy Research · doi:10.1016/0920-1211(95)00101-8 · Cited by 240
Calmodulin Mediates Ca2+-dependent Modulation of M-type K+ Channels
Gamper, N., & Shapiro, M. S. (2003) · The Journal of General Physiology · doi:10.1085/jgp.200208783 · Cited by 222
Peretz, A., Degani, N., Nachman, R., Uziyel, Y., Gibor, G., Shabat, D., & Attali, B. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.007112 · Cited by 218
Cooper, E. C., Aldape, K. D., Abosch, A., Barbaro, N. M., Berger, M. S., Peacock, W. S., Jan, Y. N., & Jan, L. Y. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090092797 · Cited by 217
Blackburn-Munro, G., & Jensen, B. S. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02924-2 · Cited by 208
Miceli, F., Soldovieri, M. V., Ambrosino, P., Barrese, V., Migliore, M., Cilio, M. R., & Taglialatela, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216867110 · Cited by 188
Disruption of the Epilepsy KCNQ2 Gene Results in Neural Hyperexcitability
Watanabe, H., Nagata, E., Kosakai, A., Nakamura, M., Yokoyama, M., Tanaka, K., & Sasai, H. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750028.x · Cited by 182
Hernandez, C. C., Zaika, O., Tolstykh, G. P., & Shapiro, M. S. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.148304 · Cited by 169
Singh, N. A., Otto, J. F., Jill Dahle, E., Pappas, C., Leslie, J. D., Vilaythong, A., Noebels, J. L., Steve White, H., Wilcox, K. S., & Leppert, M. F. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.154971 · Cited by 150
Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability
Watanabe, H. (2000) · Neuroscience Research · doi:10.1016/s0168-0102(00)81544-8 · Cited by 148
Molecular basis for ligand activation of the human KCNQ2 channel
Li, X., Zhang, Q., Guo, P., Fu, J., Mei, L., Lv, D., Wang, J., Lai, D., Ye, S., Yang, H., et al. (2020) · Cell Research · doi:10.1038/s41422-020-00410-8 · Cited by 143
Anxiolytic Effects of Maxipost (BMS-204352) and Retigabine via Activation of Neuronal Kv7 Channels
Korsgaard, M. P. G., Hartz, B. P., Brown, W. D., Ahring, P. K., Strøbæk, D., & Mirza, N. R. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.083923 · Cited by 141
Transcriptional repression of the M channel subunit Kv7.2 in chronic nerve injury
Rose, K., Ooi, L., Dalle, C., Robertson, B., Wood, I. C., & Gamper, N. (2011) · Pain · doi:10.1016/j.pain.2010.12.028 · Cited by 141
D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures
Tober, C., Rostock, A., Rundfeldt, C., & Bartsch, R. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00073-8 · Cited by 139
Retigabine: Chemical Synthesis to Clinical Application
Blackburn-Munro, G., Dalby‐Brown, W., Mirza, N. R., Mikkelsen, J. D., & Blackburn-Munro, R. E. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2005.tb00033.x · Cited by 135
KCNQ/M‐currents contribute to the resting membrane potential in rat visceral sensory neurons
Wladyka, C. L., & Kunze, D. L. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.113308 · Cited by 134
Lange, W., Geißendörfer, J. K., Schenzer, A., Grötzinger, J., Seebohm, G., Friedrich, T., & Schwake, M. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.052282 · Cited by 132
Regulation of KCNQ2/KCNQ3 Current by G Protein Cycling
Suh, B.-C., Horowitz, L. F., Hirdes, W., Mackie, K., & Hille, B. (2004) · The Journal of General Physiology · doi:10.1085/jgp.200409029 · Cited by 130
Wickenden, A. D., Krajewski, J. L., London, B., Wagoner, P. K., Wilson, W. A., Clark, S., Roeloffs, R., McNaughton-Smith, G. A., & Rigdon, G. C. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.043216 · Cited by 129
Du, X., Hao, H., Gigout, S., Huang, D., Yang, Y., Li, L., Wang, C., Sundt, D., Jaffe, D. B., Zhang, H., et al. (2014) · Pain · doi:10.1016/j.pain.2014.08.025 · Cited by 129
Flupirtine: A Review of its Pharmacological Properties, and Therapeutic Efficacy in Pain States
Friedel, H. A., & Fitton, A. (1993) · Drugs · doi:10.2165/00003495-199345040-00007 · Cited by 126
KCNQ4 channel activation by BMS-204352 and retigabine
Schrøder, R. L., Jespersen, T., Christophersen, P., Strøbæk, D., Jensen, B., & Olesen, S. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00029-6 · Cited by 123
Zheng, Q., Fang, D., Liu, M., Cai, J., Wan, Y., Han, J., & Xing, G. (2012) · Pain · doi:10.1016/j.pain.2012.12.005 · Cited by 123
Linley, J. E., Rose, K., Patil, M., Robertson, B., Akopian, A. N., & Gamper, N. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2297-08.2008 · Cited by 122
Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction
Nappi, P., Miceli, F., Soldovieri, M. V., Ambrosino, P., Barrese, V., & Taglialatela, M. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02404-2 · Cited by 122
Xiong, Q., Sun, H., & Li, M. (2007) · Nature Chemical Biology · doi:10.1038/nchembio874 · Cited by 118
Activation of Kv7 (KCNQ) voltage-gated potassium channels by synthetic compounds
Xiong, Q., GAO, Z., Wang, W., & LI, M. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.11.010 · Cited by 117
Tatulian, L., & Brown, D. A. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.039842 · Cited by 114
The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels
Bentzen, B. H., Schmitt, N., Calløe, K., Brown, W. D., Grunnet, M., & Olesen, S. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.07.001 · Cited by 93
The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain site
Padilla, K. M., Wickenden, A. D., Gerlach, A. C., & McCormack, K. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.08.071 · Cited by 88
Blue-Gray Mucocutaneous Discoloration: A New Adverse Effect of Ezogabine
Garin Shkolnik, T., Feuerman, H., Didkovsky, E., Kaplan, I., Bergman, R., Pavlovsky, L., & Hodak, E. (2014) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.8895 · Cited by 86
Activation of KCNQ5 channels stably expressed in HEK293 cells by BMS-204352
Dupuis, D. S., Schrøder, R. L., Jespersen, T., Christensen, J. K., Christophersen, P., Jensen, B., & Olesen, S. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01287-6 · Cited by 79
HLA-DRB1*16: 01-DQB1*05 02 is a novel genetic risk factor for flupirtine-induced liver injury
Nicoletti, P., Werk, A. N., Sawle, A., Shen, Y., Urban, T. J., Coulthard, S. A., Bjornsson, E. S., Cascorbi, I., Floratos, A., Stammschulte, T., et al. (2016) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000209 · Cited by 79
Roeloffs, R., Wickenden, A. D., Crean, C. S., Werness, S., McNaughton-Smith, G. A., Stables, J. P., McNamara, J. O., Ghodadra, N., & Rigdon, G. C. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.137794 · Cited by 69
M‐type K+ channels in peripheral nociceptive pathways
Du, X., Gao, H., Jaffe, D., Zhang, H., & Gamper, N. (2018) · British Journal of Pharmacology · doi:10.1111/bph.13978 · Cited by 68
Gabapentin Is a Potent Activator of KCNQ3 and KCNQ5 Potassium Channels
Manville, R. W., & Abbott, G. W. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.112953 · Cited by 67
Synthesis and Evaluation of Potent KCNQ2/3-Specific Channel Activators
Kumar, M., Reed, N. L., Liu, R., Aizenman, E., Wipf, P., & Tzounopoulos, T. (2016) · Molecular Pharmacology · doi:10.1124/mol.115.103200 · Cited by 65
Wu, Z., Li, L., Xie, F., Du, J., Zuo, Y., Frost, J. A., Carlton, S. M., Walters, E. T., & Yang, Q. (2017) · Journal of Neurotrauma · doi:10.1089/neu.2016.4789 · Cited by 65
Kv7 (KCNQ) Channel Modulators and Neuropathic Pain
Munro, G., & Dalby-Brown, W. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm060989l · Cited by 62
Abd-Elsayed, A. A., Ikeda, R., Jia, Z., Ling, J., Zuo, X., Li, M., & Gu, J. G. (2015) · Molecular Pain · doi:10.1186/s12990-015-0048-8 · Cited by 59
Xu, W., Wu, Y., Bi, Y., Tan, L., Gan, Y., & Wang, K. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-49 · Cited by 59
Self-citationActivation of Peripheral KCNQ Channels Attenuates Inflammatory Pain
Hayashi, H., Iwata, M., Tsuchimori, N., & Matsumoto, T. (2014) · Molecular Pain · doi:10.1186/1744-8069-10-15 · Cited by 58
AKAP79/150 Signal Complexes in G-Protein Modulation of Neuronal Ion Channels
Zhang, J., Bal, M., Bierbower, S., Zaika, O., & Shapiro, M. S. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4446-10.2011 · Cited by 57
Concomitant facilitation of GABAA receptors and KV7 channels by the non‐opioid analgesic flupirtine
Klinger, F., Geier, P., Dorostkar, M. M., Chandaka, G. K., Yousuf, A., Salzer, I., Kubista, H., & Boehm, S. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01821.x · Cited by 56
Wu, Y.-J., Boissard, C. G., Greco, C., Gribkoff, V. K., Harden, D. G., He, H., L'Heureux, A., Kang, S. H., Kinney, G. G., Knox, R. J., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm034073f · Cited by 54
Hirano, K., Kuratani, K., Fujiyoshi, M., Tashiro, N., Hayashi, E., & Kinoshita, M. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.11.043 · Cited by 52
Qi, J., Zhang, F., Mi, Y. M., Fu, Y., Xu, W., Zhang, D.-Q., Wu, Y., Du, X., Jia, Q., Wang, K., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.01.010 · Cited by 50
Self-citationOtto, J. F., Yang, Y., Frankel, W. N., Wilcox, K. S., & White, H. S. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.65703.x · Cited by 49
Structure of a Ca2+/CaM:Kv7.4 (KCNQ4) B-Helix Complex Provides Insight into M Current Modulation
Xu, Q., Chang, A., Tolia, A., & Minor, D. L. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.11.023 · Cited by 49
Zhang, F., Mi, Y., Qi, J., Li, J., Si, M., Guan, B., Du, X., An, H., & Zhang, H. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02232.x · Cited by 44
Gopalakrishnan, M., & Shieh, C. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.5.437 · Cited by 42
Desensitization of Chemical Activation by Auxiliary Subunits
Gao, Z., Xiong, Q., Sun, H., & Li, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802426200 · Cited by 41
The ubiquitous flavonoid quercetin is an atypical KCNQ potassium channel activator
Redford, K. E., & Abbott, G. W. (2020) · Communications Biology · doi:10.1038/s42003-020-1089-8 · Cited by 39
Gao, H., Boillat, A., Huang, D., Liang, C., Peers, C., & Gamper, N. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620598114 · Cited by 38
COMPARISON OF FLUPIRTINE MALEATE AND DIHYDROCODEINE IN PATIENTS FOLLOWING SURGERY
Moore, R. A., Bullingham, R. E. S., SIMPSON, S., O’Sullivan, G., Evans, P. J., McQuay, H. J., & LLOYD, J. W. (1983) · British Journal of Anaesthesia · doi:10.1093/bja/55.5.429 · Cited by 37
Teng, B.-C., Song, Y., Zhang, F., Ma, T.-Y., Qi, J.-L., Zhang, H.-L., Li, G., & Wang, K. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.33 · Cited by 36
Self-citationZhang, F., Liu, Y., Tang, F., Liang, B., Chen, H., Zhang, H., & Wang, K. (2019) · The FASEB Journal · doi:10.1096/fj.201802848rr · Cited by 35
Self-citationDjouhri, L., Malki, M. I., Zeidan, A., Nagi, K., & Smith, T. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1608552 · Cited by 35
Analgesic efficacy and safety of oral flupirtine in the treatment of cancer pain.
Scheef, W. (1987) · PubMed · Cited by 34
Cai, J., Fang, D., Liu, X., Song, L., Ren, J., & Xing, G. (2015) · Oncology Reports · doi:10.3892/or.2015.3718 · Cited by 32
Visceral Hyperalgesia Induced by Forebrain-Specific Suppression of Native Kv7/KCNQ/M-Current in Mice
Bi, Y., Chen, H., Su, J., Cao, X., Bian, X., & Wang, K. (2011) · Molecular Pain · doi:10.1186/1744-8069-7-84 · Cited by 32
Self-citationGreene, D. L., Kosenko, A., & Hoshi, N. (2018) · Epilepsia · doi:10.1111/epi.14541 · Cited by 31
Li, L., Li, J., Zuo, Y., Dang, D., Frost, J. A., & Yang, Q. (2019) · The Journal of Pain · doi:10.1016/j.jpain.2018.11.001 · Cited by 31
Herrmann, W. M., Kern, U., & Aigner, M. (1987) · PubMed · Cited by 29
Blom, S. M., Schmitt, N., & Jensen, H. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008251 · Cited by 28
Wu, Y., Boissard, C. G., Chen, J., Fitzpatrick, W., Gao, Q., Gribkoff, V. K., Harden, D., He, H., Knox, R. J., Natale, J. T., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.01.069 · Cited by 28
Flupirtine and retigabine as templates for ligand-based drug design of K V 7.2/3 activators
Surur, A. S., Bock, C., Beirow, K., Wurm, K. W., Schulig, L., Kindermann, M. K., Siegmund, W., Bednarski, P. J., & Link, A. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c9ob00511k · Cited by 28
Sulfide Analogues of Flupirtine and Retigabine with Nanomolar KV7.2/KV7.3 Channel Opening Activity
Bock, C., Surur, A. S., Beirow, K., Kindermann, M. K., Schulig, L., Bodtke, A., Bednarski, P. J., & Link, A. (2019) · ChemMedChem · doi:10.1002/cmdc.201900112 · Cited by 27
Clinical trial of flupirtine maleate in patients with migraine
Million, R. R., Finlay, B. R., & Whittington, I. R. (1984) · Current Medical Research and Opinion · doi:10.1185/03007998409109581 · Cited by 27
Combination Therapy with Flupirtine and Opioid: Studies in Rat Pain Models
Goodchild, C. S., Kolosov, A., Tucker, A. P., & Cooke, I. (2008) · Pain Medicine · doi:10.1111/j.1526-4637.2008.00514.x · Cited by 25
Deeks, E. D. (2011) · CNS Drugs · doi:10.2165/11205950-000000000-00000 · Cited by 25
Ezogabine skin discoloration is reversible after discontinuation
Mathias, S. V., & Abou-Khalil, B. W. (2017) · Epilepsy & Behavior Case Reports · doi:10.1016/j.ebcr.2017.01.001 · Cited by 20
Activation of KCNQ2/3 Potassium Channels by Novel Pyrazolo[1,5-a]pyrimidin-7(4H)-One Derivatives
Jia, C., Qi, J., Zhang, F., Mi, Y. M., Zhang, X., Chen, X., Liu, L., Du, X., & Zhang, H. (2011) · Pharmacology · doi:10.1159/000327384 · Cited by 20
Liu, R., Tzounopoulos, T., & Wipf, P. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00097 · Cited by 19
Antinociceptive Efficacy of Retigabine and Flupirtine for Gout Arthritis Pain
Zhang, F., Liu, S., Jin, L., Tang, L., Zhao, X., Yang, T., Wang, Y., Huo, B., Liu, R., & Li, H. (2020) · Pharmacology · doi:10.1159/000505934 · Cited by 19
Zhang, F., Liu, Y., Zhang, D., Fan, X., Shao, D., & Li, H. (2019) · Pharmacology · doi:10.1159/000496422 · Cited by 19
Self-citationCapuano, A., Corato, A. D., Treglia, M., Tringali, G., & Navarra, P. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.11.002 · Cited by 17
Successful Use of Flupirtine in Refractory Neuropathic Pain Due to Small Fiber Neuropathy
Mishra, S., Choudhary, P., Joshi, S., & Bhatnagar, S. (2013) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909112441387 · Cited by 12
Byrne, E. J. (1987) · Postgraduate Medical Journal · doi:10.1136/pgmj.63.735.67-b · Cited by 8
Flupirtine, an Effective Analgesic, but Hepatotoxicity Should Limit Its Use
Puljak, L. (2018) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000003355 · Cited by 7
Development of an Electrophysiological Assay for Kv7 Modulators on IonWorks Barracuda
Wilenkin, B., Burris, K. D., Eastwood, B. J., Sher, E., Williams, A. C., & Priest, B. T. (2019) · Assay and Drug Development Technologies · doi:10.1089/adt.2019.942 · Cited by 3
Cited by
Alles, S., & Smith, P. A. (2021) · Frontiers in Pain Research · doi:10.3389/fpain.2021.750583 · Cited by 87
“2 protein expression (69, 70) Mechanism of action yet to be”
BackgroundStructural insights into the lipid and ligand regulation of a human neuronal KCNQ channel
Zheng, Y. Y., Liu, H., Chen, Y., Dong, S., Wang, F., Wang, S., Li, G., Shu, Y., & Xu, F. (2021) · Neuron · doi:10.1016/j.neuron.2021.10.029 · Cited by 88
Ma, D., Zhong, L., Yan, Z., Yao, J., Zhang, Y., Ye, F., Huang, Y., Lai, D., Yang, W., Hou, P., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2207067119 · Cited by 61
Voltage-gated potassium channels and genetic epilepsy
Zheng, Y., & Chen, J. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1466075 · Cited by 40
Qiu, Q., Yang, M., Gong, D., Liang, H., & Chen, T. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01766 · Cited by 39
Metadata
- Authors
- Liu, Y., Bian, X., & Wang, K.
- Affiliations
- Qingdao University (CN)
- Peking University (CN)
- Corresponding author
- Wang, KeWei
- ORCID
- Venue
- Handbook of Experimental Pharmacology
- Publisher
- Springer International Publishing
- Published
- 2021
- Volume
- 267
- Pages
- 231-251
- ISSN
- 0171-2004 (ISSN-L)
- 1865-0325
- OpenAlex
- W3142768988
- Cited by
- 36
- References
- 107
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 9 · 2023: 9 · 2022: 5 · 2021: 3
- FWCI
- 10.93
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Handbook of experimental pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- Kv7 channels, KCNQ channels, M-current, retigabine, flupirtine, epilepsy, pain, nociception, neuronal hyperexcitability, antiepileptic drugs, adverse drug reactions
- MeSH terms
- Anticonvulsants, Epilepsy, Humans, Neurons, Pain, KCNQ Potassium Channels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.